Abstract
A papaverine based pharmacophore model for PDE10A inhibition was generated via SBDD and used to design a library of 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal point for additional modeling, X-ray, and synthetic efforts toward increasing PDE10A inhibitory potency and selectivity versus PDE3A/B. These efforts culminated in the discovery of 29, a potent and selective brain penetrable inhibitor of PDE10A.
MeSH terms
-
Animals
-
Corpus Striatum / metabolism
-
Crystallography, X-Ray
-
Cyclic GMP / metabolism
-
Mice
-
Models, Molecular
-
Phosphodiesterase Inhibitors / chemical synthesis*
-
Phosphodiesterase Inhibitors / chemistry
-
Phosphodiesterase Inhibitors / pharmacology
-
Phosphoric Diester Hydrolases / chemistry
-
Phosphoric Diester Hydrolases / metabolism*
-
Pyrrolidines / chemical synthesis*
-
Pyrrolidines / chemistry
-
Pyrrolidines / pharmacology
-
Quinazolines / chemical synthesis*
-
Quinazolines / chemistry
-
Quinazolines / pharmacology
-
Structure-Activity Relationship
Substances
-
Phosphodiesterase Inhibitors
-
Pyrrolidines
-
Quinazolines
-
Pde10a protein, mouse
-
Phosphoric Diester Hydrolases
-
Cyclic GMP